Diabetes Innovation: The Secret Sauce

BEOften, when we think about innovation, we immediately think of hi-tech devices, software or platforms.

In the midst of this year’s Diabetes Innovation conference, and even acknowledging that many people with diabetes are joined at the hip (literally) to some pretty hi-tech tools, it is worth slowing down for a moment to consider the value and efficacy of decidedly low-tech solutions.

Earlier this year, Susannah Fox (a speaker at this year’s conference) coauthored a report published by the Pew Research Center entitled Tracking for Health. This report collects survey data showing that while 60% of U.S adults track diet or exercise, and 33% track their own health — 49% track only in their heads, 34% use paper and only 21% use technology (web, app, device) for personal tracking.

People with diabetes are certainly well-represented among the 33% of the population who are self-identified health care self-trackers — but remember, most self-trackers are decidedly low-tech. [Read more…]

Bookmark and Share

Wellaho CEO Naser Partovi Presents a Prescribable App

PartoviThere are thousands of wellness apps in the app store. When we asked Naser Partovi what sets Wellaho apart from the crowd, allowing it to help individuals manage chronic conditions, he had a three-part answer:

1.  It’s a prescribable app, connecting patient and clinician, sending individually-configured alerts to the clinician as appropriate.

2.  It’s been validated through numerous clinical trials.

3.  It’s personalized medicine — the app is configured to reflect an individual’s history and experience (e.g., diagnosed with diabetes 10 years ago, not taking insulin).

For conditions subject to the preventable readmission rule, Wellaho customers are the hospitals that would be on the hook financially for a readmission: the hospital is the party most interested in preventing the readmission because it will not be able to bill for the readmission if it is for a condition on the Medicare list (currently COPD, pneumonia and acute myocardial infarction). For other conditions, the customer is the insurance company covering an individual with a chronic condition.

Join Naser Partovi at Diabetes Innovation 2013, and hear more about Wellaho — and a new soon-to-be unveiled product as well.

Have a listen to our interview (press play); read the transcript after the jump.

Naser Partovi (Wellaho) Diabetes Innovation Interview 08 2013

[Read more…]

Bookmark and Share